2024
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.
Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, Fanelli G, Serretti A. The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges. CNS Spectrums 2024, 1-15. PMID: 39655426, DOI: 10.1017/s1092852924002268.Peer-Reviewed Original ResearchAnxiety disordersPost-traumatic stress disorderPsychedelic-assisted psychotherapyObsessive-compulsive disorderSubstance use disordersPsychotic spectrumStandard antidepressantsResearch to clinical practiceTreating moodStress disorderAddictive behaviorsPsychopharmacological researchPsychiatric conditionsPsilocybinEvidence of efficacyAnxietyMethodological limitationsDisordersMoodMethodological constraintsMethodological rigorEvidence basePotential paradigm shiftLong-term efficacyCultural stigma
2014
The Syndemic Illness of HIV and Trauma: Implications for a Trauma-Informed Model of Care
Brezing C, Ferrara M, Freudenreich O. The Syndemic Illness of HIV and Trauma: Implications for a Trauma-Informed Model of Care. Journal Of The Academy Of Consultation-Liaison Psychiatry 2014, 56: 107-118. PMID: 25597836, DOI: 10.1016/j.psym.2014.10.006.Peer-Reviewed Original ResearchConceptsHIV infectionTrauma-informed careHigh-risk HIV behaviorTrauma-Informed ModelCochrane Review databasesHIV risk behaviorsPrimary clinical researchIntimate partner violenceTreatment of peopleRates of traumaNegative health consequencesPosttraumatic stress disorderPoor HIVPoor adherencePractice guidelinesHIV behaviorsHIVHealth outcomesPosttraumatic sequelaeReviews databasesInfectionPoor healthClinical researchHealth consequencesStress disorder